Very rarely, the complete absence of p16 overexpression may be seen in HPVa carcinomas of the lower female genital tract [47]; this may be caused by a loss of heterozygosity [48], rarely by point mutations of the p16 gene or the silencing of the gene by promotor hypermethylation [49]. This evidence concerns the gene CDKN2A and carcinoma.